A new bioprocess achieves 97% CO2-to-amino-acid conversion while cutting costs by over 40%, bringing carbon-negative chemical manufacturing closer to industrial scale.

BEAM Circular works with multi-sector partners across the Central Valley and beyond to develop bio-based solutions that transform waste into valuable products while creating local economic ...

The building blocks of proteins, amino acids, are essential for all living things. Twenty different amino acids build the ...

A mouse study shows CAR-T cells can be engineered in vivo with precise gene editing, a potential breakthrough that could cut ...

Researchers at The Hong Kong University of Science and Technology (HKUST) have developed CarGAP, a chemo-optogenetic tool that uses vitamin B₁₂ and green light to precisely control gap junctions, the ...

Welcome to Fierce Biotech’s fifth annual layoff tracker, a resource designed to keep pace with the sector’s steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over ...

The funding, which ranks as one of the largest of its kind for a China-based drug startup, will support a portfolio of ...

In life sciences, enterprise value only emerges when generative AI is treated as a business capability and embedded into existing operating models.

A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last ...

A life sciences startup led by a former Spark Therapeutics researcher is raising funding to move a rheumatoid arthritis therapy toward clinical trials.

Global proteomics and functional analyses reveal that p53-induced ZMAT3 suppresses mitochondrial respiration by inhibiting transcription of a hexokinase, uncovering a role for ZMAT3 in transcription.